Advertisement Press Releases Archive - Page 110 of 233 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

  • Restoring Bacterial Flora From Dysbiosis

    The development of Laboratoria Smeets N.V. is the result of several years of research in the area of gastrointestinal health. Is it possible to reset intestinal bacterial flora in case of dysbiosis?

  • New Management Organisation of the Haselmeier Group

    Haselmeier was able to successfully grow over the past few years, allowing the company to carve out a solid position in the market for medical devices. In keeping with this progress, the Haselmeier Group has restructured its management organisation to ensure this forward momentum continues successfully. The company has introduced a group executive board tasked with coordination and decision-making for all Haselmeier locations. The group executive board will ensure consistent, effective management
    of the Haselmeier sites, thereby coordinating the group's strategy.

  • Connect with SHL Through our Newest Podcast Series

    To help customers better understand SHL products and services, a suite of communication tools including articles, white papers, case studies, and videos have been made available online and are updated regularly. Following the recent introduction of case studies, SHL is now excited to announce the addition of podcasts to this group, where the content is communicated directly to the listener in the form of short but informative Q&A sessions.

  • Malvern Instruments Zetasizer Nano Plays Key Role in Research to Develop 3D Cell Cultures

    Researchers at the School of Engineering and Materials Science, Queen Mary University London (QMUL), are using a Malvern Instruments Zetasizer Nano to provide particle size and charge data that is being used in the development of innovative hydrogel matrices for 3D cell culture. The Zetasizer Nano’s high performance electrophoretic light scattering capabilities are allowing researchers to better understand the nature of the electrostatic interactions between proteins and peptides. These measurements are crucial to developing bespoke cell culture platforms for the production of specific biologically significant hydrogel.

  • CurTec Launches XL Nestable Drums

    CurTec’s successful line of nestable drums is set to be expanded with the introduction of two new capacities. The 75 and 115l (20 and 30 US gal) drums will fill the product line upwards. The new 115l nestable drum is now the largest capacity in the entire CurTec packaging range.

  • Sartorius Opens New Application Centre in Shanghai

    Sartorius, a leading international laboratory and pharmaceutical equipment supplier, officially opened a new application centre at its Shanghai office last week. Among the guests, representatives from the Shanghai government, customers from the biopharmaceutical industry as well as business partners and the media attended the opening ceremony.

  • Haselmeier announces the launch of INSUPen® EZ in India by Biocon

    Haselmeier announces that Biocon, one of Asia’s premier biotechnology companies, has just launched INSUPen® EZ in India. The INSUPen EZ is a second generation pen and follows on the success of Biocon’s premier insulin delivery device INSUPen®. Under the terms of the agreement between the two companies, Biocon has worldwide distribution rights to INSUPen®
    EZ, for use with Biocon’s insulin, Basalog™ and Insugen™, and insulin analogues.